Researchers have discovered that genetic changes accumulate more rapidly in MS brain lesions than in non-lesion tissue, with distinct patterns emerging in the lesions.
A pilot study has found an existing online cognitive behavioural therapy (CBT) program from Germany is highly acceptable to people with multiple sclerosis (MS) in Australia and achieved reduced levels of MS-related fatigue.
Phase 3 trials did not show a clear advantage of evobrutinib compared to current treatments for people with relapsing MS.
On International Women’s Day, we look at the disproportionate effects MS has on Australian women and the research MS Australia is supporting to address it.
MS Australia is inviting Australians with MS, their friends, family, carers, doctors, MS staff, nurses, researchers, and the broader MS community to join in the discussion to share which areas of MS research and advocacy are most important to people both directly and indirectly affected by MS.
Launching in mid-2025, the new Australian MS app InforMS is designed to help people manage their MS, creating a “one-stop shop” to hold their health information. People living with MS explain how lived experience has shaped its design.
